Patents by Inventor Na Hee LEE

Na Hee LEE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition for enhancing therapeutic effect of stem cell, comprising immunosuppressant, and method for enhancing therapeutic effect of stem cell using same
    Patent number: 12551493
    Abstract: The present invention relates to a composition for enhancing a survival rate of stem cells, including an immunosuppressant, and to a use thereof. According to the present invention, a survival rate of stem cells can be remarkably enhanced using a composition including an immunosuppressant, and a therapeutic effect of stem cells can be improved on the basis of the enhancement. The composition can overcome an immune response caused by the administration of xenogeneic cells so as to accurately verify the stability and efficacy of cells, and thus will be able to be utilized as a mesenchymal stem cell therapeutic agent that maximizes a therapeutic effect of stem cells.
    Type: Grant
    Filed: October 21, 2020
    Date of Patent: February 17, 2026
    Assignee: SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
    Inventors: Duk Lyul Na, Jong Wook Chang, Na Kyung Lee, Jung Won Hwang, Su Hyeon Myeong, Na Hee Lee, Hyeong Seop Kim
  • COMPOSITION FOR ENHANCING THERAPEUTIC EFFECT OF STEM CELL, COMPRISING IMMUNOSUPPRESSANT, AND METHOD FOR ENHANCING THERAPEUTIC EFFECT OF STEM CELL USING SAME
    Publication number: 20220370478
    Abstract: The present invention relates to a composition for enhancing a survival rate of stem cells, including an immunosuppressant, and to a use thereof. According to the present invention, a survival rate of stem cells can be remarkably enhanced using a composition including an immunosuppressant, and a therapeutic effect of stem cells can be improved on the basis of the enhancement. The composition can overcome an immune response caused by the administration of xenogeneic cells so as to accurately verify the stability and efficacy of cells, and thus will be able to be utilized as a mesenchymal stem cell therapeutic agent that maximizes a therapeutic effect of stem cells.
    Type: Application
    Filed: October 21, 2020
    Publication date: November 24, 2022
    Inventors: Duk Lyul NA, Jong Wook CHANG, Na Kyung LEE, Jung Won HWANG, Su Hyeon MYEONG, Na Hee LEE, Hyeong Seop KIM